Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 10585 - 10592 of 12007 results

Subjective or Objective Truth? Supreme Court to Decide What Is an "Untrue" Statement of Opinion

March 5, 2014| Blog| Viewpoint

Avoid the Anti-Corruption “Blacklist:” Chinese Agency Guidance

March 5, 2014| Blog| Viewpoint

Legal Highlights in Puerto Rico's "Draft POS" for Upcoming General Obligation Bond Issue

March 5, 2014| Blog| Viewpoint

There is Such a Thing as Over-Sharing: Former Employee Forfeits Portion of Settlement Payment After Daughter Discloses Settlement on Facebook

March 5, 2014| Blog| Viewpoint

The Supreme Court Narrows SLUSA's Reach and Expands the Pool of Potential Defendants Subject to State Securities Law Class Actions

March 4, 2014| Blog| Viewpoint

Boston Discussion - NIST Framework - March 25

March 4, 2014| Blog| Viewpoint

Departments of Labor, Treasury, and Health and Human Services Issue Final and Proposed Regulations Implementing the 90-day Limit on Waiting Periods under the Affordable Care Act

March 4, 2014| Advisory| Viewpoint

California Reenters the GMO Food Labeling Arena; This Time Through the Legislature

March 4, 2014| Blog| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases